CoChat

Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice

Open access
Santamaria, Giulia, Brandi, Edoardo, Vitola, Pietro La, Grandi, Federica, Ferrara, Giovanni, Pischiutta, Francesca, Vegliante, Gloria, Zanier, Elisa R., Re, Francesca, Uccelli, Antonio, Forloni, Gianluigi, de Rosbo, Nicole Kerlero, Balducci, Claudia · 2021 · Cell Death & Differentiation
Cited by 116

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The multiplicity of systems affected in Alzheimer’s disease (AD) brains calls for multi-target therapies. Although mesenchymal stem cells (MSC) are promising candidates, their clinical application is limited because of risks related to their direct implantation in the host. This could be overcome by exploiting their paracrine action. We herein demonstrate that in vivo systemic administration of secretome collected from MSC exposed in vitro to AD mouse brain homogenates (MSC-CS), fully replicates the cell-mediated neuroreparative effects in APP/PS1 AD mice. We found a complete but transient memory recovery by 7 days, which vanished by 14 days, after a single MSC-CS intravenous administration in 12-month or 22–24-month-old mice. Treatment significantly reduced plaque load, microglia activation, and expression of cytokines in astrocytes in younger, but not aged, mice at 7 days. To optimize efficacy, we established a sustained treatment protocol in aged mice through intranasal route. Once-weekly intranasal administration of MSC-CS induced persistent memory recovery, with dramatic reduction of plaques surrounded by a lower density of β-amyloid oligomers. Gliosis and the phagocytic marker CD68 were decreased. We found a higher neuronal density in cortex and hippocampus, associated with a reduction in hippocampal shrinkage and a longer lifespan indicating healthier conditions of MSC-CS-treated compared to vehicle-treated APP/PS1 mice. Our data prove that MSC-CS displays a great multi-level therapeutic potential, and lay the foundation for identifying the therapeutic secretome bioreactors leading to the development of an efficacious multi-reparative cocktail drug, towards abrogating the need for MSC implantation and risks related to their direct use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41418-020-0592-2

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 116

Metadata

Authors
Santamaria, G., Brandi, E., Vitola, P. L., Grandi, F., Ferrara, G., Pischiutta, F., Vegliante, G., Zanier, E. R., Re, F., Uccelli, A., Forloni, G., de Rosbo, N. K., & Balducci, C.
Venue
Cell Death & Differentiation
Published
2020-07-23
Volume
28
Issue
1
Pages
203-218
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W3044766308
Cited by
116
References
15
FWCI
8.30
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice. https://app.cochat.ai/papers/10.1038/s41418-020-0592-2
The paper
Santamaria, G., Brandi, E., Vitola, P. L., Grandi, F., Ferrara, G., Pischiutta, F., Vegliante, G., Zanier, E. R., Re, F., Uccelli, A., Forloni, G., de Rosbo, N. K., & Balducci, C. (2021). Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice. Cell Death & Differentiation. https://doi.org/10.1038/s41418-020-0592-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.